Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05219149 · ClinicalTrials.gov registry record
CNS Qualitative Interview
A clinical trial of Central Nervous System Cancer, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05219149 is a study of Central Nervous System Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05219149, a study of Central Nervous System Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment.
Conditions Studied
Interventions
- BEHAVIORAL Qualitative Interviews
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2026-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05219149
The ClinicalTrials.gov registry entry for NCT05219149 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Central Nervous System Cancer appearing as the primary indexed condition, and to 1 intervention - of which Qualitative Interviews is the first listed.
NCT05219149 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05219149 about?
NCT05219149 is a clinical study titled "CNS Qualitative Interview". Explore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment.
What is the current status of trial NCT05219149?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2022-01-03. Estimated completion is 2026-07-23.
What conditions does trial NCT05219149 study?
This clinical trial studies the following conditions: Central Nervous System Cancer.
What interventions are being tested in trial NCT05219149?
The interventions under investigation include: Qualitative Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT05219149?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05219149 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Nervous System Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.